Cargando…
Safety of higher dosages of Viscum album L. in animals and humans - systematic review of immune changes and safety parameters
BACKGROUND: Viscum album L extracts (VAE, mistletoe) and isolated mistletoe lectins (ML) have immunostimulating properties and a strong dose-dependent cytotoxic activity. They are frequently used in complementary cancer treatment, mainly to improve quality of life, but partly also to influence tumou...
Autores principales: | Kienle, Gunver S, Grugel, Renate, Kiene, Helmut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180269/ https://www.ncbi.nlm.nih.gov/pubmed/21871125 http://dx.doi.org/10.1186/1472-6882-11-72 |
Ejemplares similares
-
Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research
por: Kienle, Gunver S, et al.
Publicado: (2009) -
Intralesional and subcutaneous application of Viscum album L. (European mistletoe) extract in cervical carcinoma in situ: A CARE compliant case report
por: Reynel, María, et al.
Publicado: (2018) -
Long-Term Survival of a Patient with Recurrent Dedifferentiated High-Grade Liposarcoma of the Retroperitoneum Under Adjuvant Treatment with Viscum album L. Extract: A Case Report
por: Reynel, María, et al.
Publicado: (2021) -
Long-term survival of a patient with an inoperable thymic neuroendocrine tumor stage IIIa under sole treatment with Viscum album extract: A CARE compliant clinical case report
por: Reynel, María, et al.
Publicado: (2020) -
Durable clinical remission of a skull metastasis under intralesional Viscum album extract therapy: Case report
por: Werthmann, Paul Georg, et al.
Publicado: (2018)